html5-img
1 / 21

Gonorrhea in San Francisco

Gonorrhea in San Francisco. Kyle T Bernstein Chief, Epidemiology, Research and Surveillance STD Prevention and Control Services San Francisco Department of Public Health Gonorrhea Control in Region XI: Optimizing Strategies to Reduce Morbidity Phoenix, AZ January 14, 2010.

bunme
Download Presentation

Gonorrhea in San Francisco

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gonorrhea in San Francisco Kyle T Bernstein Chief, Epidemiology, Research and Surveillance STD Prevention and Control Services San Francisco Department of Public Health Gonorrhea Control in Region XI: Optimizing Strategies to Reduce Morbidity Phoenix, AZ January 14, 2010

  2. GC Diagnoses, San Francisco City Clinic 2008

  3. Non-STD Clinic GC, SSuN

  4. Non-STD Clinic GC, SSuN

  5. Approach Screen, Treat, Treat, Screen • Screening for MSM and adolescents • Quick and appropriate treatment of index patient • Quick and appropriate treatment of partners • Rescreening in 3-6 months

  6. Screening for MSM and Adolescents • SFSTD supports dual GC/CT screening at STD clinic, jails, Magnet, sex worker clinic, and primary care clinics • Annual urogenital screening for females • <26 years old • Pregnant • IUD insertion • Rectal and pharyngeal screening for MSM/transmen/transwomen every 3-6 months • Diagnostic testing supported for patients with symptoms or who are contacts to GC • Sexual Health Promotion Team targets MSM and adolescents geographically to promote screening

  7. Quick and Appropriate Treatment of Index • Surveillance staff verify treatment of reported GC cases • Cefpodoxime 400mg + azithromycin 1 gram PO x 1 • Mosaic penA PCR for GC • Review of current treatment protocols • Transition to Ceftriaxone

  8. Exposed Re - infection Crude RR 95% CI All Patients PDPT 921 123 (13.4%) 0.89 0.72 - 1.10 No PDPT 1194 180 (15.1%) 1.0 -- MSM PDPT 724 114 (15.75%) 0.89 0.72 - 1.11 No PDPT 959 169 (17.62%) 1.0 -- MSW PDPT 144 6 (4.17%) 0.71 0.26 - 1.93 No PDPT 152 9 (5.92%) 1.0 -- Females PDPT 52 3 (5.77%) 2.39 0.41 - 13.85 No PDPT 83 2 (2.41%) 1.0 -- Quick and Appropriate Treatment of Partners • Patient-delivered partner therapy (PDPT) • Available to all patients tested at STD-supported clinical sites • Also available through InSpot • Evaluation of PDPT at STD clinic

  9. Rescreening in 3-6 months • All patients with GC encouraged to re-screen • Reminder Phone Call Pilot • Pre-pilot 29.6% of women rescreened • Pilot 56.5% of women rescreened • Two sided exact test p=0.085 • No difference for CT

  10. Acknowledgments • Julia Marcus • Robert Kohn • Sally Stephens • Ameera Snell • Monica Lee • Andrew Reynolds • Susan Philip

More Related